Pancoast tumor epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
Line 3: Line 3:
{{CMG}}{{AE}}{{Mazia}}
{{CMG}}{{AE}}{{Mazia}}
==Epidemiology and Demographics==
==Epidemiology and Demographics==
Pancoast tumors are a rare type of non-small cell lung cancers (NSCLC), account for fewer than 5% of all lung cancers.
===Prevalence===
*In the United States, the age-adjusted prevalence of pancoast tumor is estimated to be 5 per 100,000.<ref name=SEER>Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>
*The prevalence of lung cancer significantly increases among smokers and individuals with chronic exposure to risk factors for lung cancer.


The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
===Incidence===
In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
*In 2014 the incidence of [[lung cancer]] was approximately 3 cases per 100,000.<ref name="SiegelMa2014">{{cite journal|last1=Siegel|first1=Rebecca|last2=Ma|first2=Jiemin|last3=Zou|first3=Zhaohui|last4=Jemal|first4=Ahmedin|title=Cancer statistics, 2014|journal=CA: A Cancer Journal for Clinicians|volume=64|issue=1|year=2014|pages=9–29|issn=00079235|doi=10.3322/caac.21208}}</ref>
The prevalence of [disease/malignancy] is estimated to be [number] cases annually.
*According to the American Cancer Society, an estimated 3,000 nonsmoking adults will die each year from lung cancer related to breathing secondhand smoke.
IF the case-fatality rate is also known, you may use either of the following template statements:
*Each year more people die of lung cancer than breast, colon, and prostate cancers combined.
*It is unclear whether the increased incidence of lung cancer is due to increased cancers or improved cancer detection (e.g. screening techniques)


In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate of [number range]%.
===Age===
The case-fatality rate of [disease name] is approximately [number range].
* Lung cancer is more common in older adults. It is rare in people under age 45.  
IF details about prevalence according to age/race/sex are known:


Age:
===Gender===
Patients of all age groups may develop [disease name].
*Males are thought to be more predisposed to the development of lung cancer. This gender discrepancy is often attributed to the historically increased rate of smoking among males compared to females.
The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
*The male to female ratio for the incidence of lung cancer is approximately 1.4 to 1.<ref name=SEER>Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>
[Disease name] commonly affects individuals younger than/older than [number of years] years of age.
Race:
There is no racial predilection to [disease name].
[Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
Sex:
[Disease name] affects men and women equally.
[Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.
IF details about prevalence by region are known:


The majority of [disease name] cases are reported in [geographical region].
===Race===
If additional details are known about the patient population in which the disease is typically diagnosed, they may be included here. Supplementary template statements include:
*There is no racial predilection for Pancoast tumor.
 
===Developing Countries===
[Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
*The incidence of lung cancer is lower in developing countries than in developed countries. It is unknown whether this decreased incidence is due to decreased cancer rates or decreased detection rates.<ref>{{cite web | title =Gender in lung cancer and smoking research | publisher =World Health Organization | date =2004 | url =http://www.who.int/gender/documents/en/lungcancerlow.pdf| format = PDF | accessdate =2007-05-26 }}</ref>
[Chronic disease name] is usually first diagnosed among [age group].
===Developed Countries===
[Acute disease name] commonly affects [age group].
*Western Europe and the U.S. have the highest incidence of lung cancer.
 
Please help WikiDoc by adding more content here. It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.


==References==
==References==

Revision as of 18:28, 20 February 2018


Pancoast tumor Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pancoast tumor from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pancoast tumor epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pancoast tumor epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pancoast tumor epidemiology and demographics

CDC onPancoast tumor epidemiology and demographics

Pancoast tumor epidemiology and demographics in the news

Blogs on Pancoast tumor epidemiology and demographics

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Pancoast tumor epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Mazia Fatima, MBBS [2]

Epidemiology and Demographics

Pancoast tumors are a rare type of non-small cell lung cancers (NSCLC), account for fewer than 5% of all lung cancers.

Prevalence

  • In the United States, the age-adjusted prevalence of pancoast tumor is estimated to be 5 per 100,000.[1]
  • The prevalence of lung cancer significantly increases among smokers and individuals with chronic exposure to risk factors for lung cancer.

Incidence

  • In 2014 the incidence of lung cancer was approximately 3 cases per 100,000.[2]
  • According to the American Cancer Society, an estimated 3,000 nonsmoking adults will die each year from lung cancer related to breathing secondhand smoke.
  • Each year more people die of lung cancer than breast, colon, and prostate cancers combined.
  • It is unclear whether the increased incidence of lung cancer is due to increased cancers or improved cancer detection (e.g. screening techniques)

Age

  • Lung cancer is more common in older adults. It is rare in people under age 45.

Gender

  • Males are thought to be more predisposed to the development of lung cancer. This gender discrepancy is often attributed to the historically increased rate of smoking among males compared to females.
  • The male to female ratio for the incidence of lung cancer is approximately 1.4 to 1.[1]

Race

  • There is no racial predilection for Pancoast tumor.

Developing Countries

  • The incidence of lung cancer is lower in developing countries than in developed countries. It is unknown whether this decreased incidence is due to decreased cancer rates or decreased detection rates.[3]

Developed Countries

  • Western Europe and the U.S. have the highest incidence of lung cancer.

References

  1. ↑ 1.0 1.1 Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.
  2. ↑ Siegel, Rebecca; Ma, Jiemin; Zou, Zhaohui; Jemal, Ahmedin (2014). "Cancer statistics, 2014". CA: A Cancer Journal for Clinicians. 64 (1): 9–29. doi:10.3322/caac.21208. ISSN 0007-9235.
  3. ↑ "Gender in lung cancer and smoking research" (PDF). World Health Organization. 2004. Retrieved 2007-05-26.

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Pancoast_tumor_epidemiology_and_demographics&oldid=1446533"